To include your compound in the COVID-19 Resource Center, submit it here.

China’s NMPA suspends Abraxane imports after U.S. inspection

China’s suspension of the importation and sale of Celgene’s Abraxane by BeiGene following an inspection at a U.S. manufacturing site demonstrates how far the country has come in its drive to ensure safety of drugs, even those sourced from overseas.

BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160),

Read the full 445 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE